Osteoprotegerin levels are increased in serum of patients with multiple myeloma.

被引：0
|
作者：
Corso, A
Dovio, A
Sartori, ML
Rusconi, C
Klersy, C
Mangiacavalli, S
Zappasodi, P
Varettoni, M
Angeli, A
Lazzarino, M
机构：
[1] IRCCS Policlin San Matteo, Div Hematol, Pavia, Italy
[2] Univ Turin, Dipartimento Sci Clin & Biol, I-10124 Turin, Italy
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5196
引用
收藏
页码：367B / 367B
页数：1
相关论文
共 50 条
  • [21] Serum free light chain levels in asymptomatic myeloma.
    Augustson, BM
    Reid, SD
    Mead, GP
    Drayson, MT
    Child, JA
    Bradwell, AR
    BLOOD, 2004, 104 (11) : 302B - 302B
  • [22] Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls
    A Corso
    A Dovio
    C Rusconi
    M L Sartori
    C Klersy
    M Varettoni
    S Mangiacavalli
    P Zappasodi
    M Ventura
    A Angeli
    M Lazzarino
    Leukemia, 2004, 18 : 1555 - 1557
  • [23] Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls
    Corso, A
    Dovio, A
    Rusconi, C
    Sartori, ML
    Klersy, C
    Varettoni, M
    Mangiacavalli, S
    Zappasodi, P
    Ventura, M
    Angeli, A
    Lazzarino, M
    LEUKEMIA, 2004, 18 (09) : 1555 - 1557
  • [24] Monitoring serum and urine osteoprotegrin levens during the treatment of patients with multiple myeloma.
    Moreb, JS
    Zucali, JR
    Roberts, C
    BLOOD, 2003, 102 (11) : 374B - 374B
  • [25] TUMOR GROWTH IS ASSOCIATED WITH INCREASED ANGIOPOIETIN-2 SERUM LEVELS IN MULTIPLE MYELOMA PATIENTS
    Pappa, C.
    Boula, A.
    Tsirakis, G.
    Katsomitrou, V.
    Tsioutis, K.
    Hatzivassili, A.
    Spathopoulou, T.
    Miminas, I.
    Kyriakou, D.
    Alexandrakis, M.
    HAEMATOLOGICA, 2012, 97 : 596 - 596
  • [26] Serum levels of OPG, RANKL and RANKL/OPG ratios in newly-diagnosed patients with multiple myeloma. Clinical correlations
    Goranova-Marinova, Veselina
    Goranov, Stefan
    Pavlov, Pavel
    Tzvetkova, Todorka
    HAEMATOLOGICA, 2007, 92 (07) : 1000 - 1001
  • [27] Evaluation of prognostic factors in patients with multiple myeloma.
    Hungria, VTM
    Gomez, M
    Moraes, JC
    Barros, JC
    Chiattone, CS
    BLOOD, 1995, 86 (10) : 3329 - 3329
  • [28] PTEN gene deletions in patients with multiple myeloma.
    Qi, XY
    Stewart, AK
    Chang, H
    BLOOD, 2004, 104 (11) : 304B - 304B
  • [29] Increased fatty acid synthase is a therapeutic target in multiple myeloma.
    Wang, Weiqin
    Zhao, Xiaoying
    Wang, Haiyan
    Xu, Gengbo
    Zhang, Xiaohong
    BLOOD, 2006, 108 (11) : 360B - 360B
  • [30] Albuminuria and alphal microglobulinuria in patients with multiple myeloma.
    Garcia, SSM
    Bottini, PV
    Metze, IL
    Alves, MA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 679A - 679A
12345